我们报告一个类白血病反应粒细胞集落刺激因子生产肾盂尿路上皮癌的，证明免疫组化分析。
We report a case of leukemoid reaction resulting from granulocyte colony-stimulating factor producing urothelial carcinoma of the renal pelvis as evidenced on immunohistochemical analysis.
须与类白血病相鉴别，可用的检测是粒细胞碱性磷酸酶(LAP)，慢性髓性白血病较低而类白血病反应较高。
A useful test to help distinguish this disease is the leukocyte alkaline phosphatase (LAP) score, which should be low with CML and high with a leukemoid reaction.
斯普金思在一份声明中说，假如人类干细胞能够像老鼠的细胞一样反应的话，就可以为我们采用其它疗法治愈白血病赢得时间。
"If human stem cells respond in the say way as mouse cells do, it could buy us time to apply other therapies," Sipkins said in a statement.
然而，医生警告说，心脏移植手术风险很高，而且即便手术成功，防止排异反应的药物会使白血病复发。
However, doctors have warned her that a heart transplant is risky and that, even if it succeeded, the drugs used to prevent her body rejecting the new heart could prompt a recurrence of the leukaemia.
结论治疗相关性白血病对治疗反应较差，CR率极低。
Conclusion Treatment-related leukemia had relatively poor response to chemotherapy, and extremely low complete remission (CR) rate.
还有，当大多数人听到的诊断早幼粒细胞白血病，淋巴瘤或多发性骨髓瘤，他们的反应是惊愕，恐惧和难以置信。
Still, when most people hear a diagnosis of leukemia, lymphoma or myeloma they respond with shock, fear and disbelief.
树突状细胞(DC)在抗肿瘤免疫反应中起关键作用，但大多数白血病病人有DC功能缺陷。
Dendritic cell (DC) plays a key role in antitumor immune response. However, there is a deficiency of DC function in the majority of leukemia patients.
目的探讨急性淋巴细胞白血病（ALL ，急淋）患儿化疗期全身性炎症反应综合征（SIRS）的发生、发展与预后的关系。
Objective To investigate the relationship of systemic inflammatory response syndrome(SIRS) and prognosis in children of acute lymphoblastic leukemia(ALL) during chemotherapy.
费城染色体(一般出现在CML)在白血病样反应中一般不出现。
The Philadelphia chromosome (universally present in CML) is lacking in patients with leukemoid reactions.
目的观察马斯平应用于急性白血病化疗后粒细胞缺乏并感染的疗效和不良反应。
Objective To observe the curative effect and side effect of maxipime(cefepime) in treating infection caused by postchemotherapeutic granulocytopenia in patients with acute leukemia.
在骨髓中检测到特异性免疫反应，伴随着表达CD19的正常B细胞和白血病细胞的损失。
A specific immune response was detected in the bone marrow, accompanied by loss of normal B cells and leukemia cells that express CD19.
本文分析了诱导化疗过程中有血小板升高反应的33例急性白血病病人的临床资料。
The hematological data of 33 cases of acute leukemia with platelet count increased during induction chemotherapy were analysed.
常发生在有潜在疾患的病人，因为这些病妨碍了他们对感染的正常反应，例如慢性白血病、何杰金病、囊性纤维化，以及激素治疗的病人都常发生。
It occurs in patients with underlying disease which prevents normal response to infection, e. g. chronic leukaemia. Hodgkln's disease, cystic fibrosis, and patients on steroid therapy.
结论原始nk细胞白血病易发生髓外浸润，且治疗反应差、预后不良。
Conclusion Blastic NK cell leukemia has an aggressive clinical course with poor response to treatment and unfavorable prognosis.
难治性急性白血病对治疗反应差，诱导缓解率低，复发率高，生存期短，是白血病治疗中的难题，目前仍以联合化疗为主要治疗方法。
Bad reaction to treatment, low induced relieving rate, high recurrence rate, and short survival period are tough problem in the treatment of refractory acute leukemia (RAL).
还有，当大多数人听到的诊断早幼粒细胞白血病，淋巴瘤或多发性骨髓瘤，他们的反应是惊愕，恐惧和难以置信。
Still, when most people hear a diagnosis of leukemia, lymphoma or myeloma they respond with shock, fear and disbelief. Some vehemently refute all the facts, and may become angry with their physician.
其中急性白血病3例、恶性淋巴瘤4例、骨髓瘤3例、反应性增生2例、转移癌1例。
Three cases were acute leukemia, 4 malignant lymphoma, 3 multiple myeloma, 2 reactive proliferation and 1 metastatic carcinoma.
骨髓部分或全部由单一造血细胞成分取代，脾的正常结构被破坏并由单一细胞取代；其他器官单一性细胞浸润并无炎症反应，符合白血病的诊断。
All the cases with leukemia showed badly emciated, splenomegaly, spleen and bone marrow with replacement of single cell type, the infiltration of leukemic cell in lung, liver and so on.
这种反应因嗜中性粒细胞中碱性磷酸酶(lap)的大量存在而和恶性的白血病相区别。
This reaction can be distinguished from malignant WBC's by the presence of large amounts of leukocyte alkaline phosphatase (LAP) in the normal neutrophils.
一些常见的治疗反应一些常见的治疗反应白血病、淋巴瘤或骨髓瘤最常见的治疗副作用有恶心、呕吐、脱发和情绪波动。
Some General Reactions to treatment. The most common side effects of treatment for leukemia, lymphoma or myeloma include nausea and vomiting, hair loss and mood swings.
结论：DCIK能诱导机体产生特异性的免疫反应，对急性髓细胞性白血病的治疗有较好的临床疗效。
Conclusion: DCIK can induce specific immunoreaction in the immune system and has satisfactory clinical anticancer efficacy in treatment of AML.
结论：DCIK能诱导机体产生特异性的免疫反应，对急性髓细胞性白血病的治疗有较好的临床疗效。
Conclusion: DCIK can induce specific immunoreaction in the immune system and has satisfactory clinical anticancer efficacy in treatment of AML.
应用推荐